As Regeneron Pharmaceuticals (REGN) Stock Value Rose, Acadian Asset Management Raised Position; Johnson & Johnson (JNJ) Stake Held by Compton Capital Management Inc

December 17, 2017 - By Stephen Andrade

Compton Capital Management Inc increased its stake in Johnson & Johnson (JNJ) by 11.01% based on its latest 2017Q2 regulatory filing with the SEC. Compton Capital Management Inc bought 2,798 shares as the company’s stock rose 6.85% with the market. The institutional investor held 28,200 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $3.73 million, up from 25,402 at the end of the previous reported quarter. Compton Capital Management Inc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $382.72B market cap company. The stock increased 0.57% or $0.81 during the last trading session, reaching $142.46. About 12.52M shares traded or 138.39% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since December 17, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Acadian Asset Management Llc increased its stake in Regeneron Pharmaceuticals (REGN) by 2132.84% based on its latest 2017Q2 regulatory filing with the SEC. Acadian Asset Management Llc bought 1,429 shares as the company’s stock rose 21.24% with the market. The institutional investor held 1,496 shares of the health care company at the end of 2017Q2, valued at $735,000, up from 67 at the end of the previous reported quarter. Acadian Asset Management Llc who had been investing in Regeneron Pharmaceuticals for a number of months, seems to be bullish on the $40.99 billion market cap company. The stock decreased 0.84% or $3.23 during the last trading session, reaching $383.44. About 139,084 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has risen 17.40% since December 17, 2016 and is uptrending. It has outperformed by 0.70% the S&P500.

Investors sentiment decreased to 0.83 in 2017 Q2. Its down 0.03, from 0.86 in 2017Q1. It dropped, as 50 investors sold JNJ shares while 878 reduced holdings. 105 funds opened positions while 667 raised stakes. 1.73 billion shares or 0.03% less from 1.73 billion shares in 2017Q1 were reported. Community Retail Bank Na has 1.21% invested in Johnson & Johnson (NYSE:JNJ). Ahl Prns Limited Liability Partnership invested 0.12% of its portfolio in Johnson & Johnson (NYSE:JNJ). Verition Fund Management Ltd Liability Co has 0.12% invested in Johnson & Johnson (NYSE:JNJ). Gam Holdings Ag holds 1.15% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 589,249 shares. Washington-based Freestone Capital Hldgs Limited Com has invested 0.52% in Johnson & Johnson (NYSE:JNJ). Stephens Ar reported 0.73% stake. 16,220 are owned by Zevin Asset Mngmt Ltd Liability Corp. Private Group invested in 14,586 shares or 0.11% of the stock. Schulhoff And Inc reported 56,050 shares. Japan-based Hikari Power Limited has invested 3.07% in Johnson & Johnson (NYSE:JNJ). Provise Group Inc Ltd Llc holds 1.45% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 72,467 shares. United States Steel & Carnegie Pension Fund reported 3.22% in Johnson & Johnson (NYSE:JNJ). Wills Finance Grp Incorporated invested in 4.8% or 48,921 shares. State Of Tennessee Treasury Department holds 1.34% or 2.12 million shares in its portfolio. Aqr Capital Management Limited Liability Corporation owns 4.91M shares for 0.86% of their portfolio.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 13 have Buy rating, 5 Sell and 5 Hold. Therefore 57% are positive. Johnson & Johnson had 83 analyst reports since August 7, 2015 according to SRatingsIntel. Argus Research maintained the stock with “Buy” rating in Wednesday, April 20 report. Barclays Capital maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, April 20. Barclays Capital has “Overweight” rating and $120 target. The rating was maintained by Jefferies on Tuesday, March 15 with “Hold”. The rating was maintained by BMO Capital Markets on Friday, June 2 with “Buy”. The stock has “Hold” rating by Jefferies on Friday, June 16. The rating was maintained by Piper Jaffray on Tuesday, July 18 with “Hold”. The company was upgraded on Wednesday, July 20 by Argus Research. The company was maintained on Tuesday, October 17 by BMO Capital Markets. The rating was downgraded by Atlantic Securities on Friday, July 21 to “Sell”. As per Friday, October 6, the company rating was maintained by Cowen & Co.

Acadian Asset Management Llc, which manages about $65.15B and $22.08 billion US Long portfolio, decreased its stake in Petrobras Argentina Sa (NYSE:PZE) by 71,392 shares to 2.51 million shares, valued at $30.12M in 2017Q2, according to the filing. It also reduced its holding in Flexsteel Inds Inc (NASDAQ:FLXS) by 19,059 shares in the quarter, leaving it with 38,768 shares, and cut its stake in Gilead Sciences Inc (NASDAQ:GILD).

Since August 7, 2017, it had 2 insider buys, and 8 insider sales for $78.43 million activity. The insider Landry Robert E sold 468 shares worth $222,981. 56,213 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares with value of $26.67M were sold by VAGELOS P ROY. $712,500 worth of stock was sold by BROWN MICHAEL S on Thursday, October 5. 2,000 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares with value of $900,000 were sold by BAKER CHARLES A.

Investors sentiment increased to 1.38 in Q2 2017. Its up 0.12, from 1.26 in 2017Q1. It increased, as 42 investors sold REGN shares while 157 reduced holdings. 84 funds opened positions while 190 raised stakes. 71.53 million shares or 1.38% more from 70.55 million shares in 2017Q1 were reported. Schaper Benz & Wise Counsel Wi accumulated 9,022 shares. Moreover, Fmr Ltd Limited Liability Company has 0.43% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Bb&T Securities Limited Company invested in 0.02% or 2,496 shares. Susquehanna Gru Ltd Liability Partnership, a Pennsylvania-based fund reported 747 shares. 6,227 were accumulated by Sumitomo Mitsui Asset Company Limited. Da Davidson Company, Montana-based fund reported 105 shares. Cwm Ltd Liability Co reported 5 shares. Jane Street Limited Liability Corp invested 0.06% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Rothschild Asset Mgmt owns 1,014 shares for 0.01% of their portfolio. Fayez Sarofim reported 863 shares or 0% of all its holdings. Bp Public Llc holds 10,000 shares or 0.18% of its portfolio. Brown Brothers Harriman And Communication reported 0% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Trust Of Vermont holds 27 shares. Principal Inc reported 115,201 shares. Mutual Of America Cap Management reported 9,267 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: